|
Aceras BioMedical, LLC, is a healthcare focused investment firm that specializes in funding the development of novel medical innovations, by collaborating with pharmaceutical companies, biotechnology companies, and research centers from around the world. Aceras brings together strong industry expertise and dedicated capital to offer partnership opportunities and flexible investment structures to public and private healthcare companies. Aceras has experience working with therapeutic drugs and devices, including small molecules, biologics, New Chemical Entities, and repositioned/reformulated molecules. Aceras' investment take on the form of debt, convertible securities, common equity, revenue participation and variations on these themes. Unlike traditional venture and institutional investors, Aceras is not wedded to any one structure.
|